Oxygen devices and delivery systems

G Hardavella, I Karampinis, A Frille, K Sreter… - Breathe, 2019 - Eur Respiratory Soc
Oxygen use has extended from inpatient to outpatient settings for patients with chronic
pulmonary diseases and complications of hypoxaemia. This article presents an overview of …

[HTML][HTML] Lung cancer stem cells—characteristics, phenotype

G Hardavella, R George, T Sethi - Translational lung cancer …, 2016 - ncbi.nlm.nih.gov
Lung cancer remains a major cause of cancer-related deaths worldwide with unfavourable
prognosis mainly due to the late stage of disease at presentation. High incidence and …

Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions

…, B Carroll, PF Durrenberger, G Hardavella… - Nature medicine, 2019 - nature.com
The molecular alterations that occur in cells before cancer is manifest are largely uncharted.
Lung carcinoma in situ (CIS) lesions are the pre-invasive precursor to squamous cell …

Physiological techniques for detecting expiratory flow limitation during tidal breathing

NG Koulouris, G Hardavella - European Respiratory Review, 2011 - Eur Respiratory Soc
Patients with severe chronic obstructive pulmonary disease (COPD) often exhale along the
same flow–volume curve during quiet breathing as they do during the forced expiratory vital …

How to give and receive feedback effectively

G Hardavella, A Aamli-Gaagnat, N Saad, I Rousalova… - Breathe, 2017 - Eur Respiratory Soc
In most European countries, feedback is embedded in education, training and daily professional
activities. It is a valuable tool for indicating whether things are going in the right direction …

[HTML][HTML] How to keep good clinical records

…, I Rousalova, AA Gagnat, N Saad, G Hardavella - Breathe, 2016 - Eur Respiratory Soc
Clinical record keeping is integral to good professional practice and the delivery of quality
healthcare http://ow. ly/TicN305wiyc

Tumour necrosis factor, interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung …

E Boutsikou, K Domvri, G Hardavella… - … in medical oncology, 2018 - journals.sagepub.com
Background: The emergence of novel antiprogrammed cell death protein-1 (PD-1) inhibitors
in non-small cell lung cancers (NSCLC) has revolutionized the therapeutic landscape of this …

Top tips to deal with challenging situations: doctor–patient interactions

G Hardavella, A Aamli-Gaagnat, A Frille, N Saad… - Breathe, 2017 - Eur Respiratory Soc
Interactions between patients and medical practitioners can sometimes be challenging. We
have all had consultations where the interaction was not optimal, either as medical …

European Respiratory Society guideline on various aspects of quality in lung cancer care

…, F Gamarra, B Grigoriu, G Hardavella… - European …, 2023 - Eur Respiratory Soc
This European Respiratory Society guideline is dedicated to the provision of good quality
recommendations in lung cancer care. All the clinical recommendations contained were based …

Variable radiological lung nodule evaluation leads to divergent management recommendations

…, AU Wells, N Navani, G Hardavella… - European …, 2018 - Eur Respiratory Soc
Radiological evaluation of incidentally detected lung nodules on computed tomography (CT)
influences management. We assessed international radiological variation in 1) pulmonary …